MedAdvisor Solutions

Overview

MedAdvisor Solutions is a pharmacy-driven patient engagement and adherence platform for pharmaceutical brands. The current buyer-relevant read is the U.S.-focused Adheris Health / MedAdvisor Solutions business after the ANZ divestiture, not the former global consumer-facing MedAdvisor story.

Engagement & Adherence Capability Model

The framework below standardizes how Rx Almanac evaluates patient-engagement-adherence capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, MedAdvisor Solutions is evaluated as pharmacy-driven patient engagement and adherence platform for pharmaceutical brands.

Capability	Buyer should compare	MedAdvisor Solutions readout
Behavioral segmentation and journey design	Patient segmentation, barrier identification, journey mapping, personalization rules, and intervention timing.	Adjacent. Request program examples and outcomes methodology.
Omnichannel patient communications	SMS, email, web, app, phone, print, and caregiver / HCP communications with consent management.	Core. MedAdvisor is strongest in pharmacy-driven patient messaging.
Adherence coaching and persistence analytics	Refill reminders, adherence risk scoring, persistence tracking, motivational support, and outcomes measurement.	Core. THRiV and legacy Adheris assets support adherence programs. Validate in RFP. Current revenue pressure makes production references important.
Care-team escalation and human support	Nurse, coach, call-center, or case-manager escalation when digital nudges are insufficient.	Not the main buying reason for MedAdvisor Solutions; validate only if the SOW includes care-team escalation and human support.
Education content and program measurement	Disease education, onboarding content, MLR-ready materials, survey instruments, and performance reporting.	Core. Patient education and activation are central to the offering.
Hub, pharmacy, and CRM integration	Data exchange with hubs, specialty pharmacies, CRM, EHR, claims, and manufacturer reporting environments.	Validate in RFP. Confirm current U.S. pharmacy reach and data rights.

• Adheris lineage: The U.S. business has legacy manufacturer-funded adherence-program recognition.
• THRiV platform: THRiV is the named engagement platform buyers should diligence.
• Public-company disclosure trail: ASX reporting gives buyers more operating visibility than many private adherence vendors provide.

Buyer Fit

MedAdvisor fits brands that want patient activation, education, adherence, vaccine, or therapy messaging routed through pharmacy touchpoints. It is less natural as a full hub, specialty pharmacy, or reimbursement-services substitute.

Differentiators

• Pharmacy-channel engagement: MedAdvisor reaches patients through pharmacy-driven messaging rather than a standalone app-only model.

RFP Questions

• How much of the current business is U.S. manufacturer-funded versus pharmacy-funded or legacy international activity?
• What pharmacy-network reach, consent controls, message governance, and outcomes reporting are available by program?
• How do recent revenue pressure, vaccine timing, and the ANZ divestiture affect service stability?
• What therapy-specific references can MedAdvisor provide for THRiV-backed programs?

Recent Activity

• 2026-02: Public investor materials updated MedAdvisor’s operating and financial position after portfolio changes.
• 2025-11: MedAdvisor reported ongoing U.S. patient-engagement and adherence-program performance in public filings.
• 2023: Adheris Health rebranded to MedAdvisor Solutions.